Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Alexander

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Eclinicalmedicine|January 7, 2026
A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicitiesSharmili Balarajah, Laura Martinez-Gili, James L Alexander, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitisJames L Alexander, Hajir Ibraheim, Camellia Richards, et al.
The Journal of Hospital Infection|August 11, 2025
Operational considerations for the running of an NHS faecal microbiota transplant (FMT) serviceBenjamin H Mullish, Anum Javed, Rohma Ghani, et al.
BMC Gastroenterology|May 13, 2022
Effects of bowel preparation on intestinal bacterial associated urine and faecal metabolites and the associated faecal microbiomeSam T R Powles, Kate I Gallagher, Leo W L Chong, et al.
Scientific Reports|July 18, 2024
3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammationRobert W Perry, Benjamin H Mullish, James L Alexander, et al.
Scientific Reports|January 10, 2023
Rectal swabs as a viable alternative to faecal sampling for the analysis of gut microbiota functionality and compositionShiva T Radhakrishnan, Kate I Gallagher, Benjamin H Mullish, et al.
Gut|May 17, 2019
International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesisAlasdair J Scott, James L Alexander, Claire A Merrifield, et al.
Nature Communications|October 23, 2023
Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axisJonathan W Lo, Domenico Cozzetto, James L Alexander, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
The Lancet. Gastroenterology & Hepatology|December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort studyZhigang Liu, Kaixing Le, Xin Zhou, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Eclinicalmedicine|January 7, 2026
A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicitiesSharmili Balarajah, Laura Martinez-Gili, James L Alexander, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitisJames L Alexander, Hajir Ibraheim, Camellia Richards, et al.
The Journal of Hospital Infection|August 11, 2025
Operational considerations for the running of an NHS faecal microbiota transplant (FMT) serviceBenjamin H Mullish, Anum Javed, Rohma Ghani, et al.
BMC Gastroenterology|May 13, 2022
Effects of bowel preparation on intestinal bacterial associated urine and faecal metabolites and the associated faecal microbiomeSam T R Powles, Kate I Gallagher, Leo W L Chong, et al.
Scientific Reports|July 18, 2024
3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammationRobert W Perry, Benjamin H Mullish, James L Alexander, et al.
Scientific Reports|January 10, 2023
Rectal swabs as a viable alternative to faecal sampling for the analysis of gut microbiota functionality and compositionShiva T Radhakrishnan, Kate I Gallagher, Benjamin H Mullish, et al.
Gut|May 17, 2019
International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesisAlasdair J Scott, James L Alexander, Claire A Merrifield, et al.
Nature Communications|October 23, 2023
Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axisJonathan W Lo, Domenico Cozzetto, James L Alexander, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
The Lancet. Gastroenterology & Hepatology|December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort studyZhigang Liu, Kaixing Le, Xin Zhou, et al.
Pageof 6